Reversible posterior Leukoencephalopathy syndrome induced by sunitinib

被引：79

作者：

Martin, German ^{[1
]}

Bellido, Lorena ^{[1
]}

Cruz, Juan Jesus ^{[1
]}

机构：

[1] Univ Hosp Salamanca, Salamanca, Spain

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 23期

关键词：

D O I：

10.1200/JCO.2007.12.8710

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：3559 / 3559

页数：1

相关论文

共 5 条

[1]

Glusker P, 2006, NEW ENGL J MED, V354, P980

[2] Phase II trial of bexarotene capsules in patients with advanced non-small-cell lung cancer after failure of two or more previous therapies [J].

Govindan, Ramaswamy ;

Crowley, John ;

Schwartzberg, Lee ;

Kennedy, Peter ;

Williams, Charles ;

Ekstrand, Bradley ;

Sandler, Alan ;

Jaunakais, Dinah ;

Bolejack, Vanessa ;

Ghalie, Richard .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (30) :4848-4854

[3] A reversible posterior leukoencephalopathy syndrome [J].

Hinchey, J ;

Chaves, C ;

Appignani, B ;

Breen, J ;

Pao, L ;

Wang, A ;

Pessin, MS ;

Lamy, C ;

Mas, JL ;

Caplan, LR .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (08) :494-500

[4]

Ozcan C, 2006, NEW ENGL J MED, V354, P981

[5] Reversible posterior leukoencephalopathy syndrome after repeat intermediate-dose cytarabine chemotherapy in a patient with acute myeloid leukemia [J].

Saito, Bungo ;

Nakamaki, Tsuyoshi ;

Nakashima, Hidetoshi ;

Usui, Takako ;

Hattori, Norimichi ;

Kawakami, Keiichiro ;

Tomoyasu, Shigeru .

AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (04) :304-306